Suppr超能文献

蛋白激酶 C:mTORC2 打破隔离

Protein kinase C: release from quarantine by mTORC2.

机构信息

Department of Pharmacology, University of California at San Diego, La Jolla, CA 92093, USA; Division of Signaling and Gene Expression, La Jolla Institute for Immunology, La Jolla, CA 92093, USA; Sanford Consortium for Regenerative Medicine, La Jolla, CA 92093, USA.

Department of Pharmacology, University of California at San Diego, La Jolla, CA 92093, USA.

出版信息

Trends Biochem Sci. 2022 Jun;47(6):518-530. doi: 10.1016/j.tibs.2022.03.003. Epub 2022 Mar 28.

Abstract

Protein kinase C (PKC) isozymes are maintained in a 'ready-to-go' but 'safe' autoinhibited conformation until second messenger binding unleashes an autoinhibitory pseudosubstrate to allow substrate phosphorylation. However, to gain this 'ready-to-go' conformation, PKC must be processed by a series of complex priming phosphorylations, the mechanism of which was enigmatic until now. Recent findings snapped the pieces of the phosphorylation puzzle into place to unveil a process that involves a newly described motif (TOR interaction motif, TIM), a well-described kinase [mechanistic target of rapamycin complex 2 (mTORC2)], and an often-used mechanism (autophosphorylation) to prime PKC to signal. This review highlights new insights into how phosphorylation controls PKC and discusses them in the context of common mechanisms for AGC kinase regulation by phosphorylation and autophosphorylation.

摘要

蛋白激酶 C(PKC)同工酶保持在“准备就绪”但“安全”的自动抑制构象中,直到第二信使结合释放自动抑制假底物以允许底物磷酸化。然而,为了获得这种“准备就绪”的构象,PKC 必须经过一系列复杂的启动磷酸化,其机制至今仍是个谜。最近的发现将磷酸化之谜的各个部分拼接在一起,揭示了一个涉及新描述的模体(TOR 相互作用模体,TIM)、一个描述良好的激酶[雷帕霉素机制靶标复合物 2(mTORC2)]和一种常用机制(自磷酸化)的过程,该过程使 PKC 能够发出信号。这篇综述强调了对磷酸化如何控制 PKC 的新见解,并在磷酸化和自磷酸化调节 AGC 激酶的常见机制的背景下讨论了这些见解。

相似文献

1
Protein kinase C: release from quarantine by mTORC2.
Trends Biochem Sci. 2022 Jun;47(6):518-530. doi: 10.1016/j.tibs.2022.03.003. Epub 2022 Mar 28.
2
mTOR Regulation of AGC Kinases: New Twist to an Old Tail.
Mol Pharmacol. 2022 Apr;101(4):213-218. doi: 10.1124/molpharm.121.000310. Epub 2021 Jun 21.
3
mTORC2 controls the activity of PKC and Akt by phosphorylating a conserved TOR interaction motif.
Sci Signal. 2021 Apr 13;14(678):eabe4509. doi: 10.1126/scisignal.abe4509.
8
Protein kinase C: perfectly balanced.
Crit Rev Biochem Mol Biol. 2018 Apr;53(2):208-230. doi: 10.1080/10409238.2018.1442408.
9
Autoregulation of the mechanistic target of rapamycin (mTOR) complex 2 integrity is controlled by an ATP-dependent mechanism.
J Biol Chem. 2013 Sep 20;288(38):27019-27030. doi: 10.1074/jbc.M113.498055. Epub 2013 Aug 8.
10
Mammalian TOR controls one of two kinase pathways acting upon nPKCdelta and nPKCepsilon.
J Biol Chem. 1999 Dec 3;274(49):34758-64. doi: 10.1074/jbc.274.49.34758.

引用本文的文献

2
Endocannabinoid biosynthetic enzymes regulate pain response via LKB1-AMPK signaling.
Proc Natl Acad Sci U S A. 2023 Dec 26;120(52):e2304900120. doi: 10.1073/pnas.2304900120. Epub 2023 Dec 18.
3
Single-residue mutation in protein kinase C toggles between cancer and neurodegeneration.
Biochem J. 2023 Aug 30;480(16):1299-1316. doi: 10.1042/BCJ20220397.
4
Protein kinase C showcases allosteric control: activation of LRRK1.
Biochem J. 2023 Feb 14;480(3):219-223. doi: 10.1042/BCJ20220507.
6
Study of spatiotemporal regulation of kinase signaling using genetically encodable molecular tools.
Curr Opin Chem Biol. 2022 Dec;71:102224. doi: 10.1016/j.cbpa.2022.102224. Epub 2022 Oct 28.
7
TOR complex 2 is a master regulator of plasma membrane homeostasis.
Biochem J. 2022 Sep 30;479(18):1917-1940. doi: 10.1042/BCJ20220388.
8
Two Sides of the Same Coin: Protein Kinase C γ in Cancer and Neurodegeneration.
Front Cell Dev Biol. 2022 Jun 21;10:929510. doi: 10.3389/fcell.2022.929510. eCollection 2022.

本文引用的文献

1
Conventional protein kinase C in the brain: repurposing cancer drugs for neurodegenerative treatment?
Neuronal Signal. 2021 Oct 8;5(4):NS20210036. doi: 10.1042/NS20210036. eCollection 2021 Dec.
2
From structure to the dynamic regulation of a molecular switch: A journey over 3 decades.
J Biol Chem. 2021 Jan-Jun;296:100746. doi: 10.1016/j.jbc.2021.100746. Epub 2021 May 3.
3
mTORC2 controls the activity of PKC and Akt by phosphorylating a conserved TOR interaction motif.
Sci Signal. 2021 Apr 13;14(678):eabe4509. doi: 10.1126/scisignal.abe4509.
4
Protein kinase C fusion proteins are paradoxically loss of function in cancer.
J Biol Chem. 2021 Jan-Jun;296:100445. doi: 10.1016/j.jbc.2021.100445. Epub 2021 Feb 20.
5
Allostery governs Cdk2 activation and differential recognition of CDK inhibitors.
Nat Chem Biol. 2021 Apr;17(4):456-464. doi: 10.1038/s41589-020-00725-y. Epub 2021 Feb 1.
6
PHLPPing the balance: restoration of protein kinase C in cancer.
Biochem J. 2021 Jan 29;478(2):341-355. doi: 10.1042/BCJ20190765.
7
Hypothesis: Unifying model of domain architecture for conventional and novel protein kinase C isozymes.
IUBMB Life. 2020 Dec;72(12):2584-2590. doi: 10.1002/iub.2401. Epub 2020 Nov 9.
8
The 3.2-Å resolution structure of human mTORC2.
Sci Adv. 2020 Nov 6;6(45). doi: 10.1126/sciadv.abc1251. Print 2020 Nov.
10
Regulation of mTORC2 Signaling.
Genes (Basel). 2020 Sep 4;11(9):1045. doi: 10.3390/genes11091045.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验